Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

Cited by (1,002)

Items 401–500 of 1,002

1. Multimodal Therapies against Pancreatic Ductal Adenocarcinoma: A Review on Synergistic Approaches toward Ultimate Nanomedicine Treatments
   Marzia Conte, Valentina Cauda · 2022 · Advanced Therapeutics
2. The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR)
   Minsol Kim, Joshua P. Schiff, Alex T. Price, Eric Laugeman, Pamela Parker Samson, Hyun Jee Kim, Shahed Nicolas Badiyan, Lauren E. Henke · 2022 · Radiation Oncology
3. Associations of Overall Survival with Geriatric Nutritional Risk Index in Patients with Advanced Pancreatic Cancer
   Christina Grinstead, Thomas J. George, Bo Han, Saunjoo L. Yoon · 2022 · Nutrients
4. Macrophages: A rising star in immunotherapy for chronic pancreatitis
   Hong Xiang, Hao Nao Yu, Qi Zhou, Yu Wu, Jiaqi Ren, Zirui Zhao, Xufeng Tao, Deshi Dong · 2022 · Pharmacological Research
5. Polymeric micelles assisted combinatorial therapy: Is it new hope for pancreatic cancer?
   Urushi Rehman, Mohammed A. S. Abourehab, Amit Alexander, Prashant Kesharwani · 2022 · European Polymer Journal
6. The Role of Endocrine Disruption Chemical-Regulated Aryl Hydrocarbon Receptor Activity in the Pathogenesis of Pancreatic Diseases and Cancer
   Kyounghyun Kim · 2024 · International Journal of Molecular Sciences
7. Robotic pancreaticoduodenectomy in elderly and younger patients: A retrospective cohort study
   Qu Liu, Zhiming Zhao, Xiuping Zhang, Guodong Zhao, Tan X, Yuan-Xing Gao, Wan Yee Lau, Rong Liu · 2020 · International Journal of Surgery
8. Responsive Nanomaterial Delivery Systems for Pancreatic Cancer Management
   Amr Elsherbeny, Hulya Bayraktutan, Umut Can Öz, Cara Moloney, J. Ashworth, Anna M. Grabowska, Cameron Alexander · 2023 · Advanced Therapeutics
9. 3D Bioprinting of Multicellular Stem Cell‐Derived Constructs to Model Pancreatic Cell Differentiation
   Shlomit Edri, Abigail Newman Frisch, Dina Safina, Majd Machour, Janette Zavin, Limor Landsman, Christophe E. Pierreux, Francesca M. Spagnoli, Shulamit Levenberg · 2024 · Advanced Functional Materials
10. Marine bioactive compound dieckol induces apoptosis and inhibits the growth of human pancreatic cancer cells PANC‐1
    Jian Xu, Ye Yan, Lei Wang, Dong Wu, Naikuan Ye, Shi Hong Chen, Feng Li · 2020 · Journal of Biochemical and Molecular Toxicology
11. Combined chemotherapy and endoscopic ultrasound-guided intratumoral 32P implantation for locally advanced pancreatic adenocarcinoma: a pilot study
    Jeevinesh Naidu, Dylan L. Bartholomeusz, Joshua Zobel, Romina Safaeian, William Hsieh, Benjamin Crouch, Karen Ho, Deborah Calnan, Nimit Singhal, Andrew R. Ruszkiewicz et al. · 2021 · Endoscopy
12. Predictive Factors for Pancreatic Cancer and Its Early Detection Using Special Pancreatic Ultrasonography in High-Risk Individuals
    Junko Fukuda, Kenji Ikezawa, Miho Nakao, Suetsumi Okagaki, Reiko Ashida, Tatsuya Ioka, Ryoji Takada, Takuo Yamai, Nobuyasu Fukutake, Hiroyuki Uehara et al. · 2021 · Cancers
13. Breath analysis for the detection of digestive tract malignancies: systematic review
    Kim F.H. Hintzen, Julia Grote, Anne G. W. E. Wintjens, Tim Lubbers, Myrthe M.M. Eussen, Frederik‐Jan van Schooten, Nicole D. Bouvy, Andrea Peeters · 2021 · BJS Open
14. Solid Pseudopapillary Neoplasm of the Pancreas: Unfolding an Intriguing Condition
    Manuel António Alves Cruz, Pedro Moutinho-Ribeiro, Pedro Costa‐Moreira, Guilherme Macedo · 2021 · GE Portuguese Journal of Gastroenterology
15. Role of human nucleoside transporters in pancreatic cancer and chemoresistance
    Carly J. Carter, Ahmed H. Mekkawy, David Lawson Morris · 2021 · World Journal of Gastroenterology
16. Exosomes as prognostic biomarkers in pancreatic ductal adenocarcinoma—a systematic review and meta-analysis
    Ștefania Bunduc, Noémi Gede, Szilárd Váncsa, Veronika Lillik, Szabolcs Kiss, Márk Félix Juhász, Bálint Mihály Erőss, Zsolt Szakács, Cristian Gheorghe, Alexandra Mikó et al. · 2022 · Translational research
17. Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening Studies
    Sana Raoof, Richard J. Lee, Kunal Jajoo, Joseph Douglas Mancias, Timothy Richard Rebbeck, Steven J. Skates · 2022 · Cancer Epidemiology Biomarkers & Prevention
18. HNRNPC regulates RhoA to induce DNA damage repair and cancer‐associated fibroblast activation causing radiation resistance in pancreatic cancer
    Ning Xia, Nannan Yang, Qungang Shan, Ziyin Wang, Xiaoyu Liu, Yingjie Chen, Jian Lu, Wei Huang, Zhongmin Wang · 2022 · Journal of Cellular and Molecular Medicine
19. Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarcinoma: a systematic review
    Marlies Vornhülz, Sofía Antón, Bálint Mihály Erőss, Zsolt Szakács, Péter Jenő Hegyi, Ivonne Regel, Claus Belka, Maximilian Niyazi, Julia V. Mayerle, Georg Beyer · 2022 · Radiation Oncology
20. miRNAs as Molecular Biomarkers for Prostate Cancer
    Donatella Coradduzza, Tatiana Solinas, Francesca Balzano, Nicola Culeddu, Niccolò Rossi, Sara Cruciani, Emanuela Azara, Margherita Maioli, Angelo Zinellu, Maria Rosaria De Miglio et al. · 2022 · Journal of Molecular Diagnostics
21. CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer
    Siyuan Zeng, Bin Lan, Xiaofan Ren, Shuman Zhang, Daniel Schreyer, Markus Eckstein, Hai Yang, Nathalie Britzen‐Laurent, Andreas Dahl, Debabrata Mukhopadhyay et al. · 2022 · Journal of Experimental & Clinical Cancer Research
22. ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour–stromal IL-1β/NF–κB/ESE3 signalling axis
    Tiansuo Zhao, Di Xiao, Fanjie Jin, Xugang Sun, Jie Yu, Hongwei Wang, Jing Liu, Wenrun Cai, Chongbiao Huang, Xiuchao Wang et al. · 2022 · British Journal of Cancer
23. The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets
    Michela Roberto, Giulia Arrivi, Mattia Alberto Di Civita, Giacomo Barchiesi, Emanuela Pilozzi, Paolo Marchetti, Daniele Santini, Federica Mazzuca, Federica Tomao · 2023 · Frontiers in Oncology
24. Global long-term trends and spatial cluster analysis of pancreatic cancer incidence and mortality over a 30-year period using the global burden of disease study 2019 data
    Maedeh Amini, Mehdi Azizmohammad Looha, Sajjad Rahimi Pordanjani, Hamid Asadzadeh Aghdaei, Mohamad Amin Pourhoseingholi · 2023 · PLoS ONE
25. Chemoradiotherapy screening in a novel biomimetic polymer based pancreatic cancer model
    Priyanka Gupta, Stella Totti, Pedro Antonio Pérez-Mancera, Eleanor Dyke, A. Nisbet, Giuseppe Schettino, Roger P Webb, Eirini G. Velliou · 2019 · RSC Advances
26. Downregulation of the let‑7 family of microRNAs may promote insulin receptor/insulin‑like growth factor signalling pathways in pancreatic ductal adenocarcinoma
    Ekene Emmanuel Nweke, Martin Brand · 2020 · Oncology Letters
27. Pancreatic incidentalomas: Investigation and management
    Marco Del Chiaro, Robert J. Torphy, Richard David Schulick · 2021 · Journal of Internal Medicine
28. Direct Endoplasmic Reticulum Targeting by the Selective Alkylphospholipid Analog and Antitumor Ether Lipid Edelfosine as a Therapeutic Approach in Pancreatic Cancer
    Faustino Mollinedo, Consuelo Gajate · 2021 · Cancers
29. PDAC as an immune evasive disease: can 3D model systems aid to tackle this clinical problem?
    Narayanan, Shruthi, Vicent, Silve, Ponz-Sarvisé, Mariano · 2021 · Frontiers in Cell and Developmental Biology
30. A review on Stimuli-pH responsive liposomal formulation in cancer therapy
    Jayapriya, P., Pardhi, Ekta, Vasave, Ravindra, Guru, Santosh Kumar, Madan, Jitender, Mehra, Neelesh Kumar · 2023 · Journal of Drug Delivery Science and Technology
31. The metabolic time line of pancreatic cancer: Opportunities to improve early detection of adenocarcinoma
    Hunter B. Moore, Rachel Culp‐Hill, Julia A. Reisz, Peter J. Lawson, Angela Sauaia, Richard David Schulick, Marco Del Chiaro, Trevor L. Nydam, Ernest Eugene Moore, Kirk Charles Hansen et al. · 2019 · The American Journal of Surgery
32. FAM172A inhibits EMT in pancreatic cancer via ERK-MAPK signaling
    Ying Chen, Peihui Liu, Di Shen, Han Liu, Lepeng Xu, Jian Wang, Daguang Shen, He Sun, Hongkui Wu · 2020 · Biology Open
33. An Immunological Glance on Pancreatic Ductal Adenocarcinoma
    Michael Karl Melzer, Frank Arnold, Katja Stifter, Friedemann Zengerling, Ninel Azoitei, Thomas Theodor Werner Seufferlein, Christian Bolenz, Alexander Kleger · 2020 · International Journal of Molecular Sciences
34. The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma
    Soňa Čierniková, Mária Novisedláková, Dana Cholujová, Viola Števurková, Michal Mego · 2020 · Biomedicines
35. Ca2+ Signaling and Its Potential Targeting in Pancreatic Ductal Carcinoma
    Louay Bettaieb, Maxime Brulé, Axel Chomy, Mel Diedro, Malory Fruit, Eloise Happernegg, Leila Heni, Anaïs Horochowska, Mahya Housseini, Kekely Klouyovo et al. · 2021 · Cancers
36. Upper Gastrointestinal Cancer and Liver Cirrhosis
    Kuo‐Shyang Jeng, Chiung‐Fang Chang, I‐Shyan Sheen, Chi‐Juei Jeng, Chih-Hsuan Wang · 2022 · Cancers
37. High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study
    Davide Brocco, Domenico De Bellis, Pietro Di Marino, Pasquale Simeone, Antonino Grassadonia, Michele De Tursi, Tommaso Grottola, Fabio F. di Mola, Patrizia Di Gregorio, Barbara Zappacosta et al. · 2022 · Cancers
38. A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present
    Muhammad Begawan Bestari, Ignatius Ronaldi Joewono, Ari Fahrial Syam · 2024 · Biomolecules
39. Folate Intake and Risk of Pancreatic Cancer: A Systematic Review and Updated Meta-Analysis of Epidemiological Studies
    Hongjuan Fu, Jie Zeng, Chang Xin Liu, Yi Gu, Yixin Zou, Hui Chang · 2020 · Digestive Diseases and Sciences
40. Does the Use of Proton Pump Inhibitors Increase the Risk of Pancreatic Cancer? A Systematic Review and Meta-Analysis of Epidemiologic Studies
    Hee-Eun Hong, A‐Sol Kim, Mi-Rae Kim, Hae‐Jin Ko, Min Kyu Jung · 2020 · Cancers
41. GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals
    Stephen Lee Abrams, Shaw M. Akula, Akshaya K. Meher, Linda S. Steelman, Agnieszka Gizak, Przemysław Duda, Dariusz Rakus, Alberto Maria Martelli, Stefano Ratti, Lucio Cocco et al. · 2021 · Cells
42. NR5A2 transcriptional activation by BRD4 promotes pancreatic cancer progression by upregulating GDF15
    Feng Guo, Yingke Zhou, Hui Guo, Dianyun Ren, Xin Jin, Heshui Wu · 2021 · Cell Death Discovery
43. Prognostic Significance of KIF11 and KIF14 Expression in Pancreatic Adenocarcinoma
    Anna Klimaszewska‐Wiśniewska, Izabela Neska−Długosz, Karolina Buchholz, Justyna Durślewicz, Dariusz Grzanka, Anna Kasperska, Paulina Antosik, Jan Zabrzyński, Alina Grzanka, Maciej Gagat · 2021 · Cancers
44. Antiausterity Activity of Secondary Metabolites from the Roots of Ferula hezarlalehzarica against the PANC-1 Human Pancreatic Cancer Cell Line
    Mostafa Alilou, Dya Fita Dibwe, Stefan Schwaiger, Mojtaba Khodami, Jakob Troppmair, Suresh Awale, Hermann Stuppner · 2020 · Journal of Natural Products
45. Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis
    Heejung Chae, Hyehyun Jeong, Jaekyung Cheon, Hong Jae Chon, Hyewon Ryu, Il Hwan Kim, Myoung Joo Kang, Jae Ho Jeong, Baek‐Yeol Ryoo, Kyu‐pyo Kim et al. · 2020 · Therapeutic Advances in Medical Oncology
46. Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers
    Morteza Abyadeh, Anna Meyfour, Vivek Gupta, Masoud Zabet‐Moghaddam, Matthew J. Fitzhenry, Shila Shahbazian, Ghasem Hosseini Salekdeh, Mehdi Mirzaei · 2020 · International Journal of Molecular Sciences
47. A review on the role of CAFs and CAF-derived exosomes in progression and metastasis of digestive system cancers
    Bahareh Zarin, Laleh Rafiee, Parnaz Daneshpajouhnejad, Shaghayegh Haghjooy Javanmard · 2021 · Tumor Biology
48. Nanocarriers targeting the diseases of the pancreas
    Nurbanu Demirtürk, Erem Bilensoy · 2021 · European Journal of Pharmaceutics and Biopharmaceutics
49. Orai3 Regulates Pancreatic Cancer Metastasis by Encoding a Functional Store Operated Calcium Entry Channel
    Samriddhi Arora, Jyoti Tanwar, Nutan Sharma, Suman Saurav, Rajender K. Motiani · 2021 · Cancers
50. Circulating tumour DNA: a challenging innovation to develop “precision onco-surgery” in pancreatic adenocarcinoma
    Daniel Pietrasz, Elisabetta Sereni, Francesco Lancellotti, Antonio Pea, Claudio Luchini, Giulio Innamorati, Roberto Salvia, Claudio Bassi · 2022 · British Journal of Cancer
51. Extrahepatic Manifestations in Alcoholic Liver Disease
    Preetam Nath, Anil Chandra Anand · 2022 · Journal of Clinical and Experimental Hepatology
52. Long non-coding RNA PVT1: A promising chemotherapy and radiotherapy sensitizer
    Weiping Yao, Shuang Li, Ruiqi Liu, Mingyun Jiang, Liang Gao, Yanwei Lu, Xiaodong Liang, Haibo Zhang · 2022 · Frontiers in Oncology
53. A real-world analysis of nanoliposomal-irinotecan with 5-fluorouracil and folinic acid as third- or later-line therapy in patients with metastatic pancreatic adenocarcinoma
    Jung Won Chun, Sang Myung Woo, Sang Hyub Lee, Jin Ho Choi, Namyoung Park, Joo Seong Kim, In Rae Cho, Woo Hyun Paik, Woo Jin Lee, Ji Kon Ryu et al. · 2022 · Therapeutic Advances in Medical Oncology
54. Spatial genomics reveals a high number and specific location of B cells in the pancreatic ductal adenocarcinoma microenvironment of long-term survivors
    Hosein M. Aziz, Lawlaw Saida, Willem de Koning, Andrew Stubbs, Yunlei Li, Kostandinos Sideras, Elena Palacios, Jaime Feliú, Marta Mendiola, Casper H.J. van Eijck et al. · 2023 · Frontiers in Immunology
55. Retinoic acid receptor β modulates mechanosensing and invasion in pancreatic cancer cells via myosin light chain 2
    Carlos Matellan, Dariusz Lachowski, Ernesto Cortés, Kai Ning Chiam, Aleksandar Krstić, Stephen D. Thorpe, Armando E. del Río Hernández · 2023 · Oncogenesis
56. Intratumoral injection therapies for locally advanced pancreatic cancer: systematic review
    Coen Ysbrand Willink, Sjoerd F.M. Jenniskens, Nienke Johanna Maria Klaassen, Martijn W.J. Stommel, J. Frank W. Nijsen · 2023 · BJS Open
57. The Relationship between Acute and Chronic Pancreatitis with Pancreatic Adenocarcinoma: Review
    Tamara Y. Alhobayb, Rahul Peravali, Motaz H. Ashkar · 2021 · Diseases
58. Mechanoimmunology in the solid tumor microenvironment
    Matteo Golo, Peter L. H. Newman, Daryan Kempe, Maté Biro · 2024 · Biochemical Society Transactions
59. Current and projected incidence rates of pancreatic cancer in 43 countries: an analysis of the Cancer Incidence in Five Continents database
    Songting Shou, Rui Liu, Jie He, Xiaochen Jiang, Fudong Liu, Yi Li, Xiyuan Zhang, Ge’er En, Zhiqing Pu, Baojin Hua et al. · 2025 · BMJ Open Gastroenterology
60. The abrupt pancreatic duct cutoff sign on MDCT and MRI
    Andrew Johnston, Ali Serhal, Camila Lopes Vendrami, Robert J. McCarthy, Srinadh Komanduri, Jeanne M. Horowitz, Paul Nikolaidis, Frank H. Miller · 2020 · Abdominal Radiology
61. The catalytically defective receptor protein tyrosine kinase EphA10 promotes tumorigenesis in pancreatic cancer cells
    Won‐Sik Shin, Mi Kyung Park, Young Hun Lee, Kyungwoo Kim, Ho Lee, Seung‐Taek Lee · 2020 · Cancer Science
62. Effects of alcohol consumption in general, and wine in particular, on the risk of cancer development: a review
    Pierre‐Louis Teissèdre, Zuriñe Rasines-Perea, Jean-Claude Ruf, Creina S. Stockley, Arina Oana Antoce, Raquel Romano, Ursula Fradera, Rena I. Kosti · 2020 · OENO One
63. Pharmacokinetics of preoperative intraperitoneal 5-FU in patients with pancreatic ductal adenocarcinoma
    Mikael Öman, Yvonne Wettergren, Elisabeth Odin, Sofia Westermark, Peter L. J. Naredi, Oskar Hemmingsson, Helena Anna Taflin · 2021 · Cancer Chemotherapy and Pharmacology
64. Ultrasound-targeted nucleic acid delivery for solid tumor therapy
    Mark R. Schwartz, Anna C. Debski, Richard J. Price · 2021 · Journal of Controlled Release
65. Development of an Icariin-Loaded Bilosome-Melittin Formulation with Improved Anticancer Activity against Cancerous Pancreatic Cells
    Nabil A. Alhakamy, Shaimaa M. Badr-Eldin, Waleed S. Alharbi, Mohamed A. Alfaleh, Omar D. Al-hejaili, Hibah Mubarak Aldawsari, Basma Ghazi Eid, Rana Bakur Bakhaidar, Filippo Drago, Filippo Caraci et al. · 2021 · Pharmaceuticals
66. Development and validation of a novel model incorporating MRI-based radiomics signature with clinical biomarkers for distinguishing pancreatic carcinoma from mass-forming chronic pancreatitis
    Jingjing Liu, Lei Hu, Bi Hua Zhou, Chun-Gen Wu, Ying-Sheng Cheng · 2022 · Translational Oncology
67. Identification of an autophagy-related gene signature for predicting prognosis and immune activity in pancreatic adenocarcinoma
    Jiang Deng, Qian Zhang, Liping Lv, Ping Ma, Yangyang Zhang, Ning Zhao, Yanyu Zhang · 2022 · Scientific Reports
68. Preoperative Prediction of Lymph Node Metastasis of Pancreatic Ductal Adenocarcinoma Based on a Radiomics Nomogram of Dual-Parametric MRI Imaging
    Lin Shi, Ling Wang, Cuiyun Wu, Yuguo Wei, Yang Zhang, Junfa Chen · 2022 · Frontiers in Oncology
69. Trends in pancreatic cancer incidence, characteristics, and outcomes in Denmark 1980–2019: A nationwide cohort study
    Jakob Kirkegård, Anders Bo Bojesen, Mette Fugleberg Nielsen, Frank Viborg Mortensen · 2022 · Cancer Epidemiology
70. MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions
    Christian Prinz, Leonard Fehring, Robin Frese · 2022 · Cells
71. The role of NPC1L1 in cancer
    Renshuai Zhang, Jun Zeng, Wenjing Liu, Jingsen Meng, Chao Wang, Lingyu Shi, Shanbo Yang, Jing Chang, Dongming Xing · 2022 · Frontiers in Pharmacology
72. Identification and verification of CCNB1 as a potential prognostic biomarker by comprehensive analysis
    Yinzhen Zeng, Rong Fan · 2022 · Scientific Reports
73. Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment
    Asmaa Elrakaybi, Dietrich Alexander Ruess, Michael Lübbert, Michael Quante, Heiko Becker · 2022 · Cancers
74. Metformin Induces Apoptosis in Human Pancreatic Cancer (PC) Cells Accompanied by Changes in the Levels of Histone Acetyltransferases (Particularly, p300/CBP-Associated Factor (PCAF) Protein Levels)
    Izabela Szymczak-Pajor, Józef Drzewoski, Ewa Świderska, Justyna Strycharz, Anna Gabryanczyk, Jacek Kasznicki, Marta Bogdańska, Agnieszka Śliwińska · 2023 · Pharmaceuticals
75. Dynamical Behavior of a Cancer Growth Model with Chemotherapy and Boosting of the Immune System
    Shireen Rasool Jawad, Matthias Winter, Zain-Aldeen S. A. Rahman, Yasir I. A. Al‐Yasir, Anwar Zeb · 2023 · Mathematics
76. Challenges in Diagnosis and Treatment of Pancreatic Exocrine Insufficiency among Patients with Pancreatic Ductal Adenocarcinoma
    Xiaoyang Lan, Gabrielle Robin, Jessica Kasnik, Grace Wong, Omar Mohammed Abdel-Rahman · 2023 · Cancers
77. Earlier Diagnosis of Pancreatic Cancer: Is It Possible?
    Tomas Koltai · 2023 · Cancers
78. A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma
    Kosta Stosic, Oier Azurmendi Senar, Jawad Tarfouss, Christelle Bouchart, Julie Navez, Jean‐Luc Van Laethem, Tatjana Arsenijevic · 2023 · Cells
79. Comparative molecular profiling of pancreatic ductal adenocarcinoma of the head versus body and tail
    Maen Abdelrahim, Abdullah Esmail, Anup Kasi, Nestor F. Esnaola, Joanne Xiu, Yasmine Baca, Benjamin Adam Weinberg · 2024 · npj Precision Oncology
80. Mechanisms of Oral Bacterial Virulence Factors in Pancreatic Cancer
    Zhong Sun, Chenglong Xiong, Seoh Wei Teh, Jonathan Chee Woei Lim, Suresh S. Kumar, Karuppiah Thilakavathy · 2019 · Frontiers in Cellular and Infection Microbiology
81. Outcomes of Neoadjuvant Chemotherapy Versus Chemoradiation in Localized Pancreatic Cancer: A Case–Control Matched Analysis
    Asmita Chopra, Jacob C. Hodges, Adam C. Olson, Steve A. Burton, Susannah G. Ellsworth, Nathan Bahary, Aatur Dilip Singhi, Brian A. Boone, Joal D. Beane, David L. Bartlett et al. · 2020 · Annals of Surgical Oncology
82. Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban
    Floris T.M. Bosch, Frits I. Mulder, Menno Volkert Huisman, Jeffrey I. Zwicker, Marcello Di Nisio, Marc Carrier, Annelise E.M. Segers, Peter B. Verhamme, Saskia Middeldorp, Jeffrey Ian Weitz et al. · 2021 · Journal of Thrombosis and Haemostasis
83. Identification of an Autophagy-Related Pair Signature for Predicting Prognoses and Immune Activity in Pancreatic Adenocarcinoma
    Qian Zhang, Liping Lv, Ping Ma, Yangyang Zhang, Jiang Deng, Yanyu Zhang · 2021 · Frontiers in Immunology
84. Treatment and survival of patients with pancreatic ductal adenocarcinoma: 15-year national cohort
    Linn Såve Nymo, Tor Åge Myklebust, Hanne Mari Hamre, Bjørn Møller, Kristoffer Lassen · 2022 · BJS Open
85. Temporal progression of pancreatic cancer computed tomography findings until diagnosis: A large‐scale multicenter study
    Masanori Gonda, Atsuhiro Masuda, Takashi Kobayashi, Takao Iemoto, Saori Kakuyama, Takeshi Ezaki, Takuya Ikegawa, Yuichi Hirata, Hidetaka Tsumura, Kyohei Ogisu et al. · 2024 · United European Gastroenterology Journal
86. A Phase Ib Study of Single-Agent Idelalisib Followed by Idelalisib in Combination with Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
    Erkut Hasan Borazanci, Michael Jon Pishvaian, John J. Nemunaitis, Colin D. Weekes, Julie C. Huang, Nishanthan Rajakumaraswamy · 2020 · The Oncologist
87. Comprehensive Analysis of Expression, Clinicopathological Association and Potential Prognostic Significance of RABs in Pancreatic Cancer
    Shashi Anand, Mohammad Aslam Khan, Moh'd M. Khushman, Santanu Dasgupta, Seema Singh, Ajay P. Singh · 2020 · International Journal of Molecular Sciences
88. Evaluation of the In Vitro Cytotoxic Activity of Ursolic Acid PLGA Nanoparticles against Pancreatic Ductal Adenocarcinoma Cell Lines
    Adam Markowski, Paweł Migdał, Adrianna Zygmunt, Magdalena Zaremba-Czogalla, Jerzy Gubernator · 2021 · Materials
89. The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma
    Ben George, Matthew Kent, Andy Surinach, Neil Lamarre, Paul C. Cockrum · 2021 · Frontiers in Oncology
90. CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
    Bin Lan, Siyuan Zeng, Shuman Zhang, Xiaofan Ren, Yuming Xing, Isabella Kutschick, Susanne Pfeffer, Benjamin Frey, Nathalie Britzen‐Laurent, Robert Grützmann et al. · 2022 · Cancers
91. M2‐phenotype tumour‐associated macrophages upregulate the expression of prognostic predictors MMP14 and INHBA in pancreatic cancer
    Zhan‐Wen Liang, Jie Yu, Dongmei Gu, Xiao‐Meng Liu, Jin Liu, Mengyao Wu, Mengdan Xu, Meng Shen, Weiming Duan, Wei Li · 2022 · Journal of Cellular and Molecular Medicine
92. GAS41 mediates proliferation and GEM chemoresistance via H2A.Z.2 and Notch1 in pancreatic cancer
    Shilong Han, Chuanwu Cao, Rui Liu, Yifeng Yuan, Long Pan, Minjie Xu, Chao Hu, Xiaojun Zhang, Maoquan Li, Xiaoping Zhang · 2022 · Cellular Oncology
93. The Microbiome in Pancreatic Cancer-Implications for Diagnosis and Precision Bacteriophage Therapy for This Low Survival Disease
    Mwila Kabwe, Stuart G. Dashper, Joseph Tucci · 2022 · Frontiers in Cellular and Infection Microbiology
94. Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients
    Alberto Puccini, Marta Ponzano, Bruna Dalmasso, Irene Vanni, Annalice Gandini, Silvia Puglisi, Roberto Borea, Malvina Cremante, William Bruno, Virginia Andreotti et al. · 2022 · Cancers
95. A preponderance of gastrointestinal cancer patients transition into cachexia syndrome
    Linda Anne Gilmore, Santiago Olaechea, Brian W. Gilmore, Bhavani S. Gannavarapu, Christian Alvarez, Chul Woo Ahn, Puneeth Iyengar, Rodney Elwood Infante · 2022 · Journal of Cachexia Sarcopenia and Muscle
96. Periplocin exerts antitumor activity by regulating Nrf2-mediated signaling pathway in gemcitabine-resistant pancreatic cancer cells
    Eun Seo Bae, Woong Sub Byun, Chae Won Ock, Won Kyung Kim, Hyen Joo Park, Sang Kook Lee · 2022 · Biomedicine & Pharmacotherapy
97. Targeting Pancreatic Cancer with Novel Plumbagin Derivatives: Design, Synthesis, Molecular Mechanism, In Vitro and In Vivo Evaluation
    Suresh Awale, Hayato Baba, Nguyễn Duy Phan, Min Jo Kim, Juthamart Maneenet, Koichi Sawaki, Mitsuro Kanda, Tomoyuki Okumura, Tsutomu Fujii, Takuya Okada et al. · 2023 · Journal of Medicinal Chemistry
98. The use of patient-derived xenografts and patient-derived organoids in the search for new therapeutic regimens for pancreatic carcinoma. A review
    Emin Gayibov, Tomas Sychra, Alžběta Spálenková, Pavel Souček, Martin Oliverius · 2024 · Biomedicine & Pharmacotherapy
99. Early Tumor Shrinkage and Depth of Response Evaluation in Metastatic Pancreatic Cancer Treated with First Line Chemotherapy: An Observational Retrospective Cohort Study
    Caterina Vivaldi, Lorenzo Fornaro, Carla Cappelli, Irene Pecora, Silvia Catanese, Francesca Salani, Andrea Cacciato Insilla, Emanuele F. Kauffmann, Francescamaria Donati, Giulia Pasquini et al. · 2019 · Cancers
100. Temporal trends of incidence and mortality in Asian-Americans with pancreatic adenocarcinoma: an epidemiological study
     Mohamed M. Gad · 2020 · Annals of Gastroenterology